Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01571830 · ClinicalTrials.gov registry record
Improving Nutrient Intake and Growth in Children With Multiple Food Allergies
A clinical trial, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 43
- Enrollment target
NCT01571830: Completed study, sponsored by Medical College of Wisconsin.
NCT01571830 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01571830 has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
* Hypothesis 1: Food allergies are associated with poor growth which can be corrected with nutrition intervention. * More than 10% of children with multiple food allergies will have a weight-for-age z-score less than - 2 at diagnosis. The z-score is a measure of the distance from the mean value, or 50th percentile on the growth chart. A z-score of less than - 2 indicates that the child is underweight. * Growth parameters of children with multiple food allergies will improve after intervention by a team that includes a dietitian and an allergist. * Hypothesis 2: Food allergies are associated with low micronutrient intake which can be corrected with nutrition intervention. o More than 30% of children with multiple food allergies will consume less than 67% of the Dietary Reference Intake for at least one macronutrient or micronutrient at diagnosis. * Macronutrient and micronutrient intake will increase after intervention by a team that includes a dietitian and an allergist. o • Hypothesis 3: Food allergies are related to behavioral feeding problems which can be corrected with nutrition intervention. * At least 25% of children with multiple food allergies will have behavioral feeding problems at diagnosis. * Prevalence of behavioral feeding problems will decrease after nutrition intervention.
Primary Outcome
Weight for age, length/height for age, and weight for length/height z-scores will be assessed. Growth will be compared to reference standards. Growth velocity will be calculated in grams/day.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-09 |
What the finished NCT01571830 record still lists
NCT01571830 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01571830 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01571830 about?
NCT01571830 is a clinical study titled "Improving Nutrient Intake and Growth in Children With Multiple Food Allergies". * Hypothesis 1: Food allergies are associated with poor growth which can be corrected with nutrition intervention. * More than 10% of children with multiple food allergies will have a weight-for-age z-score less than - 2 at diagnosis. The z-score is a measure of the distance from the mean value, ...
What is the current status of trial NCT01571830?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2011-12. Estimated completion is 2014-09.
Who is sponsoring clinical trial NCT01571830?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia